Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Will Study Algae for Woods Hole Oceanographic Institution

NEW YORK, Dec. 19-Lynx Therapeutics said today that it has a service agreement with the Woods Hole Oceanographic Institution to study gene expression in a marine dinoflagellate that causes red tides.


Lynx will receive payments from the institute to use its Massively Parallel Signature Sequencing technology on samples of Alexandrium fundyense, an algae that can cause paralytic shellfish poisoning in people who eat contaminated shellfish.


The company's platform will be used to study the physiology of algal bloom formation and the production of neurotoxins, with the aim of creating new ways to monitor shellfish.


Financial details of the agreement were not revealed. Yesterday, Lynx also announced that it has received a delisting noticefrom Nasdaq; the company plans to appeal the notice.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.